nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—OPRM1—telencephalic ventricle—Parkinson's disease	0.0722	0.181	CbGeAlD
Remifentanil—OPRM1—nerve—Parkinson's disease	0.0455	0.114	CbGeAlD
Remifentanil—OPRD1—forebrain—Parkinson's disease	0.0277	0.0694	CbGeAlD
Remifentanil—OPRK1—forebrain—Parkinson's disease	0.0265	0.0665	CbGeAlD
Remifentanil—Pethidine—GRIN2B—Parkinson's disease	0.0207	0.443	CrCbGaD
Remifentanil—OPRM1—brainstem—Parkinson's disease	0.0195	0.049	CbGeAlD
Remifentanil—OPRM1—forebrain—Parkinson's disease	0.0189	0.0473	CbGeAlD
Remifentanil—OPRD1—head—Parkinson's disease	0.0158	0.0397	CbGeAlD
Remifentanil—OPRK1—head—Parkinson's disease	0.0152	0.0381	CbGeAlD
Remifentanil—OPRD1—nervous system—Parkinson's disease	0.015	0.0377	CbGeAlD
Remifentanil—OPRD1—central nervous system—Parkinson's disease	0.0145	0.0363	CbGeAlD
Remifentanil—OPRK1—nervous system—Parkinson's disease	0.0144	0.0361	CbGeAlD
Remifentanil—OPRK1—central nervous system—Parkinson's disease	0.0139	0.0348	CbGeAlD
Remifentanil—OPRK1—cerebellum—Parkinson's disease	0.0135	0.034	CbGeAlD
Remifentanil—OPRM1—midbrain—Parkinson's disease	0.0125	0.0313	CbGeAlD
Remifentanil—OPRM1—spinal cord—Parkinson's disease	0.0122	0.0305	CbGeAlD
Remifentanil—OPRD1—brain—Parkinson's disease	0.0115	0.0288	CbGeAlD
Remifentanil—OPRK1—brain—Parkinson's disease	0.011	0.0276	CbGeAlD
Remifentanil—OPRM1—head—Parkinson's disease	0.0108	0.0271	CbGeAlD
Remifentanil—OPRM1—nervous system—Parkinson's disease	0.0102	0.0257	CbGeAlD
Remifentanil—OPRM1—central nervous system—Parkinson's disease	0.00986	0.0247	CbGeAlD
Remifentanil—Pethidine—SLC6A3—Parkinson's disease	0.00976	0.209	CrCbGaD
Remifentanil—Alfentanil—ABCB1—Parkinson's disease	0.00813	0.174	CrCbGaD
Remifentanil—OPRM1—brain—Parkinson's disease	0.00783	0.0196	CbGeAlD
Remifentanil—Pethidine—CYP2D6—Parkinson's disease	0.00513	0.11	CrCbGaD
Remifentanil—Fentanyl—ABCB1—Parkinson's disease	0.00297	0.0638	CrCbGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00176	0.00318	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00174	0.00313	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00173	0.00313	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.0017	0.00306	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—DRD2—Parkinson's disease	0.00169	0.00305	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00167	0.003	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00165	0.00298	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—GRM5—Parkinson's disease	0.00164	0.00296	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00164	0.00295	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—TAC1—Parkinson's disease	0.00161	0.00291	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—EDN1—Parkinson's disease	0.00161	0.0029	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00159	0.00287	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00159	0.00287	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00159	0.00287	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—DRD1—Parkinson's disease	0.00158	0.00285	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—GRK5—Parkinson's disease	0.00158	0.00284	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00157	0.00283	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00157	0.00283	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00157	0.00283	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00156	0.0028	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—DGKQ—Parkinson's disease	0.00154	0.00278	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—GPR37—Parkinson's disease	0.00154	0.00278	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00154	0.00277	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—DRD3—Parkinson's disease	0.00153	0.00276	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00152	0.00274	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—IL1B—Parkinson's disease	0.00152	0.00273	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00149	0.00269	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00149	0.00268	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—VPS35—Parkinson's disease	0.00148	0.00267	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PENK—Parkinson's disease	0.00147	0.00266	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00146	0.00262	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00144	0.00259	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—TAC1—Parkinson's disease	0.00141	0.00255	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—GRM4—Parkinson's disease	0.00141	0.00255	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00141	0.00254	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.0014	0.00252	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—MAPK8—Parkinson's disease	0.00139	0.00251	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—DRD1—Parkinson's disease	0.00139	0.0025	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—HTR7—Parkinson's disease	0.00138	0.0025	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—DRD2—Parkinson's disease	0.00138	0.0025	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—GRK5—Parkinson's disease	0.00138	0.00249	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00136	0.00246	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00135	0.00243	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00135	0.00243	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00135	0.00243	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—DRD3—Parkinson's disease	0.00134	0.00242	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PENK—Parkinson's disease	0.00134	0.00241	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.0013	0.00235	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—VPS35—Parkinson's disease	0.0013	0.00234	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PENK—Parkinson's disease	0.00129	0.00233	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00129	0.00232	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00128	0.0023	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00127	0.0023	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—GRM5—Parkinson's disease	0.00125	0.00226	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—GRM4—Parkinson's disease	0.00124	0.00223	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GPR37—Parkinson's disease	0.00123	0.00221	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—DGKQ—Parkinson's disease	0.00123	0.00221	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PDYN—Parkinson's disease	0.00122	0.00221	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—HTR7—Parkinson's disease	0.00121	0.00219	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—DRD2—Parkinson's disease	0.00121	0.00219	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00121	0.00219	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—TAC1—Parkinson's disease	0.00119	0.00215	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00118	0.00213	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PENK—Parkinson's disease	0.00117	0.00212	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—DRD1—Parkinson's disease	0.00117	0.00211	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—GRK5—Parkinson's disease	0.00117	0.0021	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00115	0.00208	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—GRM5—Parkinson's disease	0.00114	0.00205	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—DRD3—Parkinson's disease	0.00113	0.00204	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00112	0.00202	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00112	0.00201	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—EDN1—Parkinson's disease	0.00111	0.002	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.0011	0.00199	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—GRM5—Parkinson's disease	0.0011	0.00198	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—VPS35—Parkinson's disease	0.0011	0.00198	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PENK—Parkinson's disease	0.00109	0.00197	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00108	0.00194	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—DGKQ—Parkinson's disease	0.00108	0.00194	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GPR37—Parkinson's disease	0.00108	0.00194	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PDYN—Parkinson's disease	0.00107	0.00194	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00107	0.00192	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—GRM4—Parkinson's disease	0.00105	0.00189	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—DRD2—Parkinson's disease	0.00103	0.00185	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—HTR7—Parkinson's disease	0.00103	0.00185	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PDYN—Parkinson's disease	0.001	0.0018	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—GRM5—Parkinson's disease	0.000998	0.0018	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PENK—Parkinson's disease	0.000992	0.00179	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000985	0.00177	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RIT2—Parkinson's disease	0.000981	0.00177	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—EDN1—Parkinson's disease	0.000972	0.00175	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—HTR2A—Parkinson's disease	0.00097	0.00175	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000968	0.00174	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000944	0.0017	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000935	0.00168	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GRK5—Parkinson's disease	0.00093	0.00168	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—GRM5—Parkinson's disease	0.000929	0.00167	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000925	0.00167	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000911	0.00164	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—DGKQ—Parkinson's disease	0.00091	0.00164	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GPR37—Parkinson's disease	0.00091	0.00164	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PDYN—Parkinson's disease	0.000908	0.00164	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000893	0.00161	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—IL6—Parkinson's disease	0.000888	0.0016	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000865	0.00156	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RIT2—Parkinson's disease	0.000861	0.00155	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—HTR2A—Parkinson's disease	0.00085	0.00153	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000849	0.00153	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—GRM5—Parkinson's disease	0.000844	0.00152	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—HTR1A—Parkinson's disease	0.00084	0.00151	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GRM4—Parkinson's disease	0.000835	0.0015	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000832	0.0015	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—TAC1—Parkinson's disease	0.000827	0.00149	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—EDN1—Parkinson's disease	0.000822	0.00148	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GRK5—Parkinson's disease	0.000816	0.00147	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—DRD1—Parkinson's disease	0.000811	0.00146	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000811	0.00146	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000808	0.00146	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000799	0.00144	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PENK—Parkinson's disease	0.000791	0.00143	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAG—Parkinson's disease	0.000791	0.00143	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00079	0.00142	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—DRD3—Parkinson's disease	0.000786	0.00142	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000783	0.00141	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000783	0.00141	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000783	0.00141	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000759	0.00137	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000737	0.00133	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000734	0.00132	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GRM4—Parkinson's disease	0.000732	0.00132	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RIT2—Parkinson's disease	0.000727	0.00131	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—TAC1—Parkinson's disease	0.000725	0.00131	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PDYN—Parkinson's disease	0.000724	0.0013	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000719	0.0013	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000718	0.00129	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—DRD1—Parkinson's disease	0.000711	0.00128	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—HTR7—Parkinson's disease	0.000711	0.00128	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—DRD2—Parkinson's disease	0.000711	0.00128	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000709	0.00128	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PENK—Parkinson's disease	0.000694	0.00125	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAG—Parkinson's disease	0.000694	0.00125	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GRK5—Parkinson's disease	0.00069	0.00124	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—DRD3—Parkinson's disease	0.000689	0.00124	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000686	0.00124	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000686	0.00124	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000686	0.00124	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GFAP—Parkinson's disease	0.00068	0.00123	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000675	0.00122	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GRM5—Parkinson's disease	0.000673	0.00121	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000662	0.00119	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000643	0.00116	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000641	0.00116	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PDYN—Parkinson's disease	0.000634	0.00114	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000627	0.00113	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—DRD2—Parkinson's disease	0.000623	0.00112	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HTR7—Parkinson's disease	0.000623	0.00112	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000623	0.00112	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GRM4—Parkinson's disease	0.000618	0.00111	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—TAC1—Parkinson's disease	0.000613	0.0011	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—DRD1—Parkinson's disease	0.000601	0.00108	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000599	0.00108	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GFAP—Parkinson's disease	0.000597	0.00107	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FGF20—Parkinson's disease	0.00059	0.00106	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GRM5—Parkinson's disease	0.00059	0.00106	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAG—Parkinson's disease	0.000586	0.00106	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PENK—Parkinson's disease	0.000586	0.00106	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—DRD3—Parkinson's disease	0.000582	0.00105	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—HTR7—Parkinson's disease	0.00058	0.00105	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—DRD2—Parkinson's disease	0.00058	0.00105	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000572	0.00103	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—EDN1—Parkinson's disease	0.000569	0.00103	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000549	0.00099	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000548	0.000988	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000544	0.00098	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PDYN—Parkinson's disease	0.000536	0.000966	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—INSR—Parkinson's disease	0.000528	0.000951	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—DRD2—Parkinson's disease	0.000527	0.000949	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HTR7—Parkinson's disease	0.000527	0.000949	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGF20—Parkinson's disease	0.000517	0.000932	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GFAP—Parkinson's disease	0.000504	0.000908	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000502	0.000904	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—EDN1—Parkinson's disease	0.000499	0.000899	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FGB—Parkinson's disease	0.000499	0.000899	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GRM5—Parkinson's disease	0.000499	0.000898	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000498	0.000897	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HTR1A—Parkinson's disease	0.000496	0.000894	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TAC1—Parkinson's disease	0.000489	0.000881	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000481	0.000866	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—DRD1—Parkinson's disease	0.000479	0.000864	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000464	0.000837	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—DRD3—Parkinson's disease	0.000464	0.000836	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—INSR—Parkinson's disease	0.000463	0.000834	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGB—Parkinson's disease	0.000437	0.000788	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGF20—Parkinson's disease	0.000437	0.000788	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000436	0.000786	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR1A—Parkinson's disease	0.000435	0.000784	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000433	0.000781	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TAC1—Parkinson's disease	0.000429	0.000772	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000424	0.000764	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—EDN1—Parkinson's disease	0.000422	0.00076	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—DRD1—Parkinson's disease	0.00042	0.000757	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—DRD2—Parkinson's disease	0.00042	0.000756	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HTR7—Parkinson's disease	0.00042	0.000756	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—DRD3—Parkinson's disease	0.000407	0.000733	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000406	0.000732	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—INSR—Parkinson's disease	0.000391	0.000705	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADRBK1—Parkinson's disease	0.00038	0.000685	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGB—Parkinson's disease	0.00037	0.000666	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000369	0.000665	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—DRD2—Parkinson's disease	0.000368	0.000663	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR7—Parkinson's disease	0.000368	0.000663	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR1A—Parkinson's disease	0.000368	0.000663	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TAC1—Parkinson's disease	0.000362	0.000653	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—DRD1—Parkinson's disease	0.000355	0.00064	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF2—Parkinson's disease	0.000352	0.000634	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—DRD3—Parkinson's disease	0.000344	0.00062	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF1R—Parkinson's disease	0.00034	0.000613	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EDN1—Parkinson's disease	0.000336	0.000606	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000321	0.000579	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR7—Parkinson's disease	0.000311	0.000561	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—DRD2—Parkinson's disease	0.000311	0.000561	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NGF—Parkinson's disease	0.000309	0.000557	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF2—Parkinson's disease	0.000308	0.000556	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF1R—Parkinson's disease	0.000298	0.000537	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EDN1—Parkinson's disease	0.000295	0.000531	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HTR2A—Parkinson's disease	0.000294	0.00053	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOE—Parkinson's disease	0.000273	0.000493	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NGF—Parkinson's disease	0.000271	0.000488	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF2—Parkinson's disease	0.000261	0.00047	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR2A—Parkinson's disease	0.000258	0.000465	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF1R—Parkinson's disease	0.000252	0.000454	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EDN1—Parkinson's disease	0.000249	0.000449	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOE—Parkinson's disease	0.00024	0.000432	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—INS—Parkinson's disease	0.000234	0.000421	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NGF—Parkinson's disease	0.000229	0.000412	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR2A—Parkinson's disease	0.000218	0.000393	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—INS—Parkinson's disease	0.000205	0.000369	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOE—Parkinson's disease	0.000203	0.000365	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CASP3—Parkinson's disease	0.000174	0.000313	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—INS—Parkinson's disease	0.000173	0.000312	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6—Parkinson's disease	0.000173	0.000311	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK8—Parkinson's disease	0.00016	0.000288	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CASP3—Parkinson's disease	0.000152	0.000275	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6—Parkinson's disease	0.000151	0.000273	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK8—Parkinson's disease	0.00014	0.000252	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CASP3—Parkinson's disease	0.000129	0.000232	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6—Parkinson's disease	0.000128	0.000231	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK8—Parkinson's disease	0.000118	0.000213	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6—Parkinson's disease	0.000102	0.000184	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6—Parkinson's disease	8.95e-05	0.000161	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6—Parkinson's disease	7.56e-05	0.000136	CbGpPWpGaD
